Darier's Disease

Clinical guidelines for managing hereditary keratosis disorders, evaluating ATP2A2 mutations, SERCA2 calcium pump dysfunction, and reviewing oral retinoids and infection prevention.

⏱️ 5 min read

Table of Contents

🧠 Standard of Care & Symptoms

Darier's Disease, also known as Darier-White disease, is a rare, autosomal dominant genetic skin disorder characterized by the development of hyperkeratotic (crusted) papules in seborrheic areas of the body.

🧬 Diagnostics & Calcium Signaling Pathophysiology

Diagnosis is established through clinical evaluation, characteristic nail pathology, skin biopsy showing acantholysis and dyskeratosis, and molecular genetic testing.

Pathophysiology of SERCA2 Calcium Pump Defects

The skin lesions in Darier's Disease are driven by a failure of cellular calcium regulation:

πŸ’Š Symptom Management & Retinoids

No curative therapy is available. Treatment is symptomatic, focusing on normalizing skin differentiation, managing flare-ups, and preventing severe secondary infections.

Topical & Systemic Retinoid Therapies

Infection Prophylaxis & Trigger Avoidance

πŸ”¬ Active Clinical Trials

Clinical trials are currently evaluating topical gene correction vehicles, targeted low-dose retinoid protocols, and novel barrier-promoting antimicrobials.

NCT06922923: Topical SERCA2 Gene Correction Formulation (S-101)

Evaluating the safety and efficacy of a topical gene delivery vehicle designed to restore functional ATP2A2/SERCA2 expression in keratinocytes to reverse acantholysis.

Key Inclusion: Age 18 to 65, genetically confirmed ATP2A2 mutation, and active plaques on the trunk.
NCT07050723: Low-Dose Oral Alitretinoin vs. Acitretin

A randomized trial comparing the efficacy and tolerability of oral Alitretinoin to standard Acitretin in clearing severe Darier's disease lesions.

Key Inclusion: Age ≥ 18, severe Darier's disease, and failure of prior topical treatments.
NCT07119723: Topical Omiganan Pentahydrochloride (Antimicrobial Peptide)

Evaluating a topical antimicrobial peptide gel to reduce *Staphylococcus aureus* colonization and decrease malodorous flares in intertriginous plaques.

Key Inclusion: Age 12 to 70, confirmed Darier's disease with intertriginous involvement, and history of recurrent skin infections.
Important: Browse actively recruiting clinical trials in our Clinical Trials Catalogue to find a local study.

πŸ—ΊοΈ Next Steps After Diagnosis

If you have recently been diagnosed with Darier's Disease, establish these clinical care pathways:

  1. Optimize Your Skin Environment: Use air conditioning during hot months, and wear loose, breathable clothing to reduce friction and sweat build-up.
  2. Establish an Antiseptic Wash Routine: Incorporate antiseptic washes (like chlorhexidine or dilute bleach baths twice weekly) to prevent bacterial overgrowth.
  3. Schedule Genetic Counseling: Discuss the 50% inheritance risk for family planning.
  4. Watch for Viral Infections: Contact your dermatologist immediately if you develop painful, fluid-filled blisters (which may indicate a herpes infection).

❓ Patient FAQ

Q: Is Darier's disease contagious?
A: No. Darier's disease is an inherited genetic disorder caused by mutations in the ATP2A2 gene. It cannot be transmitted from person to person. However, the skin lesions can develop secondary bacterial or viral infections, which must be treated.

Q: What triggers a flare-up of Darier's disease?
A: The most common triggers are heat, humidity, ultraviolet light (sunlight), friction (such as tight clothing or rubbing), sweat, and skin infections. Avoiding these triggers is a key part of managing the condition.

Get the Free 2026 Clinical AI Directory

Email us at caleb@openphr.org to receive our exclusive directory of over 150 open-source models and clinical trial databases.

Request Directory via Email